Arcadia Biosciences, Inc.
RKDA
$1.12
$0.076.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.56M | 5.89M | 4.44M | 3.16M | 4.24M |
| Total Receivables | 425.00K | 831.00K | 1.26M | 3.58M | 3.07M |
| Inventory | 1.21M | 1.46M | 1.49M | 1.29M | 904.00K |
| Prepaid Expenses | 156.00K | 214.00K | 383.00K | 727.00K | 931.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 96.00K | 96.00K |
| Total Current Assets | 6.36M | 8.39M | 7.58M | 8.85M | 9.24M |
|
|
|||||
| Total Current Assets | 6.36M | 8.39M | 7.58M | 8.85M | 9.24M |
| Net Property, Plant & Equipment | 8.00K | 10.00K | 22.00K | 47.00K | 178.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 39.00K | 39.00K | 39.00K | 39.00K | 39.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 143.00K | 148.00K | 148.00K | 4.06M | 4.06M |
| Total Assets | 6.55M | 8.58M | 7.79M | 12.99M | 13.52M |
|
|
|||||
| Total Accounts Payable | 1.45M | 2.02M | 1.56M | 1.90M | 703.00K |
| Total Accrued Expenses | 286.00K | -- | -- | 30.00K | 1.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 11.00K | 21.00K | 155.00K |
| Total Finance Division Other Current Liabilities | 320.00K | 270.00K | 270.00K | 270.00K | 483.00K |
| Total Other Current Liabilities | 320.00K | 270.00K | 270.00K | 270.00K | 483.00K |
| Total Current Liabilities | 2.06M | 2.29M | 1.84M | 2.22M | 2.56M |
|
|
|||||
| Total Current Liabilities | 2.06M | 2.29M | 1.84M | 2.22M | 2.56M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 347.00K | 856.00K | 1.42M | 1.87M | 4.73M |
| Total Liabilities | 2.41M | 3.14M | 3.26M | 4.09M | 7.29M |
|
|
|||||
| Common Stock & APIC | 285.36M | 285.32M | 285.27M | 285.18M | 285.10M |
| Retained Earnings | -281.22M | -279.88M | -280.74M | -276.28M | -278.88M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.14M | 5.44M | 4.53M | 8.91M | 6.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.14M | 5.44M | 4.53M | 8.91M | 6.22M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.14M | 5.44M | 4.53M | 8.91M | 6.22M |
|
|
|||||